-80%

est. 2Y upside i

Series C

Stage: exit. Country: Germany

Rank

#4106

Sector

Digital Orthodontics

Est. Liquidity

~1Y

Data Quality

Data: Medium

Equity in PlusDental, if offered at the $138M valuation, would have been highly risky.

Last updated: March 10, 2026

Bull (5%)+100%

In a highly optimistic, counterfactual scenario, PlusDental could have achieved substantial organic growth and market leadership, leading to an independent exit at $276 million, providing a strong return for common shareholders after liquidation preferences.

Base (70%)0%

PlusDental was acquired by Straumann Group for approximately $138 million, a valuation consistent with its last funding round. After accounting for $88 million in liquidation preferences, common shareholders realized a minimal return on their equity, approximately $50 million in total.

Bear (25%)-70%

Intense competition, regulatory pressures, and operational challenges could have led to a distressed sale or liquidation below liquidation preferences, resulting in common shareholders receiving no value for their equity.

Est. time to liquidity~0.5 years

Preference Stack Risk

severe

Funding Intensity

64%

Investors held $88 million in liquidation preferences on a $138 million valuation, meaning common shareholders would receive approximately $50 million in an exit at the acquisition price.

Secondary Liquidity

none

There is no secondary market for PlusDental equity, as the company was acquired and integrated into Straumann Group.

Questions to Ask at the Interview

Strategic questions based on PLUS DENTAL's data — designed to show you've done your homework.

  • 1

    “Given the acquisition of PlusDental by Straumann Group and the subsequent discontinuation of the PlusDental brand, how has the integration into DrSmile progressed, and what is the long-term vision for the combined entity in the European clear aligner market?”

  • 2

    “PlusDental had a hybrid revenue model and faced high regulatory barriers. How is DrSmile, under the Straumann Group, navigating these regulatory complexities and optimizing the hybrid model for sustainable growth and profitability?”

  • 3

    “Considering that PlusDental was acquired at a valuation similar to its last funding round, and the significant liquidation preferences, what is the current equity strategy for employees within the DrSmile/Straumann Group, and what are the anticipated liquidity timelines for new equity grants?”

Community

Valuation Sentiment

Our model estimates -80% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.